A New Path in Cancer Treatment: mRNA Based Therapy Takes Center Stage Recent years have seen significant advancements in cancer research, particularly in personalized approaches that harness the immune system's power to combat tumors.
The latest development comes from Moderna and Merck, which have released promising results for an mRNA based therapy combining their respective treatments, intismeran and pembrolizumab (Keytruda).
This breakthrough has the potential to revolutionize cancer treatment by offering a more effective and targeted approach.